Madison Vaccines Overview

  • Founded
  • 2012
Founded
  • Status
  • Out of Business
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Out of Business

Madison Vaccines General Information

Description

Developer of immune-activating therapies intended to treat prostate cancer. The company's immune-activating therapies stimulate immune system to destroy residual tumor cells before they develop into overt bone metastases and to delay the need for castration therapies, enabling patients to get cured at an early stage of cancer and avail a healthy life.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Drug Delivery
Biotechnology
Primary Office
  • 505 South Rosa Road
  • Suite 201
  • Madison, WI 53719
  • United States
+1 (646) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Madison Vaccines Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Sep-2017 0000 Completed Out of Business
3. Early Stage VC (Series A) 10-Mar-2015 0000 0000 000.00 Completed Clinical Trials - Phase 2
2. Grant 27-Aug-2014 $1.5M $8M Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 14-Jan-2014 $8M $8M 0000 Completed Clinical Trials - Phase 2
To view Madison Vaccines’s complete valuation and funding history, request access »

Madison Vaccines Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.0 00 00 00 00 00.000
To view Madison Vaccines’s complete cap table history, request access »

Madison Vaccines Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of immune-activating therapies intended to treat prostate cancer. The company's immune-activating therapies st
Therapeutic Devices
Madison, WI
2 As of 2015
0000
00000000 00 0000

000000 0

it, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
0000 00000000
Ra'anana, Israel
000 As of 0000
000.00
000000 - 000 000.00

00000000

et, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
0000000000000
Saint Louis, MO
0 As of 0000
00000
0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Madison Vaccines Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Urogen Pharma Formerly VC-backed Ra'anana, Israel 000 000.00 000000 - 000 000.00
000000000 00000000 Venture Capital-Backed Saint Louis, MO 0 00000 0000
0000000 0000000000 Venture Capital-Backed Schlieren, Switzerland 00 000.00 00000000000 000.00
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000000 00000000 Corporation Pasadena, CA 000 00.000 000000 - 000 00.000
You’re viewing 5 of 9 competitors. Get the full list »

Madison Vaccines Board Members (5)

Name Representing Role Since
Paul Weiss Ph.D Venture Investors Board Member 000 0000
You’re viewing 1 of 5 board members. Get the full list »

Madison Vaccines Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial